In our previous studies, the increased expression of phase 2 detoxifying enzymes (e.g., GSTs and NQO1) by I3C and DIM in breast cancer cell lines correlated with the upregulation of Nrf2 [81]. The gene discussed is NFE2L2; the disease is breast cancer.